CRP and cardiovascular disorder: Over the last decade, research in elite athletes (Larsen et al., 2020) and healthy recreationally active (Fedewa et al., 2017; Hinton et al., 2006; Quinn et al., 2021) female cohorts have consistently demonstrated an intermediate‐to‐high risk of cardiovascular disease (CRP >1 mg L−1) with long‐term oral contraceptive pill (OCP) use.